|

QHRD107 capsule，Venclexta and Azacitidine Clinical Trials

1 actively recruiting trial

Also known as: CDK9 inhibitors

Pipeline

Phase 2: 1

Top Sponsors

  • Changzhou Qianhong Bio-pharma Co., Ltd.1

Indications

  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)1
  • Cancer1

Other1 trial

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.